Physician profile
John A Pilcher
NPI 1356339550
$214,280.39
in general payments reported to CMS, 2019-2025
38 companies · $17K in 2025
The $17K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $37K · 2021: $28K · 2022: $19K · 2023: $53K · 2024: $41K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $81K · Consulting Fee: $21K · Travel and Lodging: $4,989 · Food and Beverage: $2,427 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $81,200.00 |
| Consulting Fee | $20,900.00 |
| Travel and Lodging | $4,989.43 |
| Food and Beverage | $2,427.15 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $189,463.14 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Ethicon INC. | $20,900.00 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $543.15 | 2019-2023 | Xifaxan |
| Medtronic, INC. | $499.64 | 2022-2025 | Signia, Ligasure, Sonicision |
| Ethicon Endo-Surgery INC. | $450.00 | 2022 | |
| Daiichi Sankyo INC. | $449.83 | 2020-2023 | Injectafer |
| Novo Nordisk INC | $295.55 | 2019-2025 | Wegovy |
| Lilly USA, LLC | $238.12 | 2022-2025 | Zepbound, Jardiance, Mounjaro |
| Phathom Pharmaceuticals, INC. | $149.33 | 2024 | Voquezna |
| Endo Pharmaceuticals INC. | $145.80 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $118.45 | 2021-2025 | Contrave |
| Lexington Medical, INC. | $104.25 | 2024-2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Depuy Synthes Sales INC. | $100.00 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $89.75 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $88.02 | 2020-2023 | Gattex |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $71.28 | 2022 | |
| Shire North American Group INC | $54.60 | 2019 | |
| Microline Surgical INC | $46.50 | 2021-2025 | |
| Redhill Biopharma INC. | $43.27 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $39.57 | 2021-2025 | Exparel |
| Innocoll Pharmaceuticals Limited | $37.56 | 2021-2022 | |
| Shield Therapeutics INC | $33.55 | 2023-2024 | Accrufer |
| Intra-Sana Laboratories | $32.85 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Ethicon US, LLC | $31.26 | 2022-2025 | Echelon Flex |
| Cook Medical LLC | $26.87 | 2022 | |
| Lsi Solutions INC | $26.51 | 2022 | |
| Rhythm Pharmaceuticals, INC. | $26.26 | 2023 | Imcivree |
| Integra Lifesciences Corporation | $22.49 | 2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Stryker Corporation | $20.29 | 2021 | |
| Kerecis Limited | $20.18 | 2020 | |
| Vivus LLC | $18.59 | 2020 | |
| Tela Bio, INC. | $16.98 | 2022 | |
| Boston Scientific Corporation | $16.52 | 2025 | Spyglass Discover |
| Standard Bariatrics, INC. | $15.74 | 2022 | |
| W. L. Gore & Associates, INC. | $15.59 | 2023 | Seamguard |
| Davol INC. | $14.25 | 2021 | |
| Covidien LP | $11.99 | 2019 | |
| Kvk-Tech, INC. | $2.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pilcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.